Table 2.
Clinical characteristics of thyroid tumor samples.
| Sample | Sex | Age (years) | TI-RADS | TPOAb (IU/ml) | TGAb (IU/ml) | Combined disease |
|---|---|---|---|---|---|---|
| PTC1 | F | 30 | 4B | 517.4 | 504.7 | HT |
| PTC2 | F | 54 | 4A | 68.6 | 200.9 | HT |
| PTC3 | F | 42 | 4B | 277.8 | 120.0 | HT |
| PTC4 | F | 31 | 4A | 190.5 | 295.6 | HT |
| PTC5 | F | 53 | 5 | 8.5 | 16.1 | Non |
| PTC6 | M | 37 | 5 | 5.0 | 61.6 | Non |
| PTC7 | F | 28 | 5 | 8.2 | 12.5 | Non |
| PTC8 | M | 32 | 4A | 104.4 | NA | HT |
| PTC9 | F | 34 | 4C | 239.7 | >4,000 | HT |
| PTC10 | F | 25 | 5 | 92.7 | 38.1 | HT |
F, female; M, male; PTC, papillary thyroid carcinoma; TI-RADS, Thyroid Imaging Reporting and Data System; TGAb, anti-thyroglobulin antibody; TPOAb, thyroid peroxidase antibody; NA, not available.